Publications

Data from Visualizing Cancer Heterogeneity at the Molecular and Cellular Levels: Lessons from Rosetta

Authors: RJA Goodwin, JF Marshall, G Poulogiannis, M Yuneva, KM Brindle, Z Takáts, ...

E-pub date: 13 Jan 2025

Journal name:

Predicting Personalised Therapeutic Combinations in Non-Small Cell Lung Cancer Using In Silico Modelling

Authors: MA Clarke, CG Barker, A Nicholls, MP Handler, L Pickard, A Shah, D Walter, ...

E-pub date: 12 Jan 2025

Journal name:

TDP1 splice-site mutation causes HAP1 cell hypersensitivity to topoisomerase I inhibition

Authors: CG Goh, A Bader, T-A Tran, R Belotserkovskaya, G D'Alessandro, S Jackson

E-pub date: 11 Jan 2025

Journal name: Nucleic Acids Research

KLF5 loss sensitizes cells to ATR inhibition and is synthetic lethal with ARID1A deficiency.

Authors: SW Awwad, C Doyle, J Coulthard, AS Bader, N Gueorguieva, S Lam, V Gupta, R ...

E-pub date: 8 Jan 2025

Journal name: Nature Communications

Selective Photocatalytic C-H Oxidation of 5-Methylcytosine in DNA.

Authors: T Yan, Y Chen, B Mortishire-Smith, A Simeone, A Hofer, S Balasubramanian

E-pub date: 2 Jan 2025

Journal name: Angew Chem Int Ed Engl

Insights from the bottom-up development of LGR5-targeting immunotherapeutics.

Authors: N Mueller, MA de la Roche, M de la Roche

E-pub date: 30 Dec 2024

Journal name: Immunotherapy Advances

The EstroGene2.0 database for endocrine therapy response and resistance in breast cancer.

Authors: Z Li, F Chen, L Chen, J Liu, D Tseng, F Hadi, S Omarjee, K Kishore, J Kent,...

E-pub date: 19 Dec 2024

Journal name: NPJ Breast Cancer

Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer

Authors: L Veghini, D Pasini, R Fang, P Delfino, D Filippini, C Neander, C Vicentini...

E-pub date: 3 Dec 2024

Journal name: Nat Commun

Filters

Research Groups

Core Facilities

Start date

End date

Data from Visualizing Cancer Heterogeneity at the Molecular and Cellular Levels: Lessons from Rosetta

Predicting Personalised Therapeutic Combinations in Non-Small Cell Lung Cancer Using In Silico Modelling

TDP1 splice-site mutation causes HAP1 cell hypersensitivity to topoisomerase I inhibition

KLF5 loss sensitizes cells to ATR inhibition and is synthetic lethal with ARID1A deficiency.

Selective Photocatalytic C-H Oxidation of 5-Methylcytosine in DNA.

Insights from the bottom-up development of LGR5-targeting immunotherapeutics.

The EstroGene2.0 database for endocrine therapy response and resistance in breast cancer.

Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Data from Visualizing Cancer Heterogeneity at the Molecular and Cellular Levels: Lessons from Rosetta

Predicting Personalised Therapeutic Combinations in Non-Small Cell Lung Cancer Using In Silico Modelling

TDP1 splice-site mutation causes HAP1 cell hypersensitivity to topoisomerase I inhibition

KLF5 loss sensitizes cells to ATR inhibition and is synthetic lethal with ARID1A deficiency.

Selective Photocatalytic C-H Oxidation of 5-Methylcytosine in DNA.

Insights from the bottom-up development of LGR5-targeting immunotherapeutics.

The EstroGene2.0 database for endocrine therapy response and resistance in breast cancer.

Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer